# Cluster2-21 Analysis

## Proteins: 

ARL4C, BABAM2, BLTP3A, CCT2, CCT3, CCT4, CCT6A, CCT6B, CCT7, CCT8, CDC73, DIAPH1, DOK3, FBXO45, GNA12, GNAS, GNG2, GPSM2, LONP1, MFAP4, MIOS, MLLT10, MOV10, NLRP2, PDCD5, PDCL, PDCL3, PFDN1, PFDN5, SHB, SKIC3, SKIC8, TLE3, TXNDC9, UNC45B, VBP1

### Cytosolic Protein Folding and Chaperone System

#### Summary

The human protein system analyzed in this study consists of 35 proteins that are primarily involved in protein binding, cytosolic and cytoplasmic localization, and protein folding. The majority of these proteins are associated with chaperone-mediated protein folding, ATP-dependent protein folding, and chaperonin-containing T-complexes. Additionally, several proteins are involved in signal transduction, G-protein-coupled receptor signaling, and Wnt signaling pathways. Based on the cellular location and function, we propose the name "Cytosolic Protein Folding and Chaperone System" for this protein system.

#### References

1. Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011). Molecular chaperones in protein folding and proteostasis. Nature, 475(7356), 324-332. [DOI: 10.1038/nature10317](https://doi.org/10.1038/nature10317)

2. Saibil, H. (2013). Chaperone machines for protein folding, unfolding and disaggregation. Nature Reviews Molecular Cell Biology, 14(10), 630-642. [DOI: 10.1038/nrm3658](https://doi.org/10.1038/nrm3658)

3. Balchin, D., Hayer-Hartl, M., & Hartl, F. U. (2016). In vivo aspects of protein folding and quality control. Science, 353(6294), aac4354. [DOI: 10.1126/science.aac4354](https://doi.org/10.1126/science.aac4354)

4. Kampinga, H. H., & Craig, E. A. (2010). The HSP70 chaperone machinery: J proteins as drivers of functional specificity. Nature Reviews Molecular Cell Biology, 11(8), 579-592. [DOI: 10.1038/nrm2941](https://doi.org/10.1038/nrm2941)

5. Nollen, E. A., & Morimoto, R. I. (2002). Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. Journal of Cell Science, 115(Pt 14), 2809-2816. [DOI: 10.1242/jcs.00061](https://doi.org/10.1242/jcs.00061)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 35 | TLE3, BLTP3A, ARL4C, CCT3, LONP1, BABAM2, DOK3, GNA12, MLLT10, GPSM2, FBXO45, GNG2, MFAP4, GNAS, DIAPH1, UNC45B, CDC73, MIOS, SKIC3, SKIC8, VBP1, CCT2, PFDN5, PFDN1, MOV10, CCT6A, CCT7, SHB, PDCL3, PDCD5, PDCL, TXNDC9, CCT8, CCT4, NLRP2 |
| cytosol | 27 | ARL4C, CCT3, CCT6B, LONP1, BABAM2, GPSM2, GNAS, DIAPH1, UNC45B, CDC73, MIOS, SKIC3, SKIC8, VBP1, CCT2, PFDN5, MOV10, CCT6A, CCT7, SHB, PDCL3, PDCD5, PDCL, TXNDC9, CCT8, CCT4, NLRP2 |
| cytoplasm | 22 | ARL4C, BABAM2, DOK3, GNA12, GPSM2, FBXO45, DIAPH1, UNC45B, MIOS, SKIC3, SKIC8, VBP1, PFDN5, PFDN1, CCT6A, CCT7, PDCL3, PDCD5, PDCL, TXNDC9, CCT8, NLRP2 |
| nucleus | 14 | TLE3, ARL4C, BABAM2, MLLT10, FBXO45, DIAPH1, CDC73, SKIC3, SKIC8, VBP1, PFDN5, MOV10, PDCD5, TXNDC9 |
| nucleoplasm | 12 | TLE3, LONP1, BABAM2, MLLT10, CDC73, MIOS, SKIC3, SKIC8, SHB, PDCL3, CCT8, CCT4 |
| protein folding | 11 | CCT3, CCT6B, VBP1, CCT2, PFDN5, PFDN1, CCT6A, CCT7, PDCL3, CCT8, CCT4 |
| ATP binding | 10 | CCT3, CCT6B, LONP1, CCT2, MOV10, CCT6A, CCT7, CCT8, CCT4, NLRP2 |
| unfolded protein binding | 10 | CCT3, CCT6B, VBP1, CCT2, PFDN5, PFDN1, CCT6A, CCT7, CCT8, CCT4 |
| protein stabilization | 10 | CCT3, VBP1, CCT2, PFDN5, PFDN1, CCT6A, CCT7, PDCL3, CCT8, CCT4 |
| ATP hydrolysis activity | 9 | CCT3, CCT6B, LONP1, CCT2, MOV10, CCT6A, CCT7, CCT8, CCT4 |
| protein folding chaperone | 9 | CCT3, CCT6B, CCT2, PFDN1, CCT6A, CCT7, PDCL3, CCT8, CCT4 |
| extracellular exosome | 9 | CCT3, GNG2, GNAS, CCT2, CCT6A, CCT7, PDCD5, CCT8, CCT4 |
| chaperone-mediated protein folding | 8 | CCT3, UNC45B, CCT2, CCT6A, CCT7, PDCL3, CCT8, CCT4 |
| ATP-dependent protein folding chaperone | 7 | CCT3, CCT6B, CCT2, CCT6A, CCT7, CCT8, CCT4 |
| chaperonin-containing T-complex | 7 | CCT3, CCT6B, CCT2, CCT6A, CCT7, CCT8, CCT4 |
| plasma membrane | 6 | ARL4C, DOK3, GNA12, GNG2, DIAPH1, SHB |
|  telomere maintenance via telomerase | 6 | CCT3, CCT2, CCT6A, CCT7, CCT8, CCT4 |
| toxin transport | 6 | CCT3, CCT6B, CCT2, CCT7, CCT8, CCT4 |
|  establishment of protein localization to telomere | 6 | CCT3, CCT2, CCT6A, CCT7, CCT8, CCT4 |
|  protein localization to Cajal body | 6 | CCT3, CCT2, CCT6A, CCT7, CCT8, CCT4 |
|  telomerase RNA localization to Cajal body | 6 | CCT3, CCT2, CCT6A, CCT7, CCT8, CCT4 |
| microtubule | 6 | CCT3, CCT2, CCT6A, CCT7, CCT8, CCT4 |
| RNA binding | 5 | CCT3, DIAPH1, MOV10, CCT6A, CCT4 |
| binding of sperm to zona pellucida | 5 | CCT3, CCT2, CCT7, CCT8, CCT4 |
| cell body | 5 | CCT3, CCT2, CCT7, CCT8, CCT4 |
| apoptotic process | 5 | BABAM2, SHB, PDCL3, PDCD5, NLRP2 |
| signal transduction | 4 | TLE3, BABAM2, SHB, PDCL |
| zona pellucida receptor complex | 4 | CCT3, CCT2, CCT8, CCT4 |
| centrosome | 4 | GPSM2, TXNDC9, CCT8, CCT4 |
| extracellular region | 4 | FBXO45, MFAP4, CCT2, CCT8 |
| Wnt signaling pathway | 3 | TLE3, CDC73, SKIC8 |
| identical protein binding | 3 | BLTP3A, LONP1, GPSM2 |
| GTPase activity | 3 | ARL4C, GNA12, GNAS |
| GTP binding | 3 | ARL4C, GNA12, GNAS |
| membrane | 3 | LONP1, GNG2, GNAS |
| metal ion binding | 3 | GNA12, MLLT10, GNAS |
| G protein-coupled receptor signaling pathway | 3 | GNA12, GPSM2, GNG2 |
| heterotrimeric G-protein complex | 3 | GNA12, GNG2, GNAS |
| protein-containing complex | 3 | MLLT10, GPSM2, PDCL3 |
| amyloid-beta binding | 3 | VBP1, PFDN5, PFDN1 |
| negative regulation of amyloid fibril formation | 3 | VBP1, PFDN5, PFDN1 |
| prefoldin complex | 3 | VBP1, PFDN5, PFDN1 |
| transcription corepressor activity | 2 | TLE3, PFDN5 |
| negative regulation of DNA-templated transcription | 2 | TLE3, PFDN5 |
| negative regulation of canonical Wnt signaling pathway | 2 | TLE3, PFDN5 |
| pore complex assembly | 2 | CCT3, CCT8 |
|  peptidyl-tyrosine phosphorylation | 2 | LONP1, PDCL3 |
| chaperone-mediated protein complex assembly | 2 | LONP1, CCT2 |
| DNA damage response | 2 | BABAM2, FBXO45 |
| negative regulation of apoptotic process | 2 | BABAM2, CDC73 |
| cell division | 2 | BABAM2, GPSM2 |
| secretory granule membrane | 2 | DOK3, DIAPH1 |
| ficolin-1-rich granule membrane | 2 | DOK3, DIAPH1 |
| G-protein beta/gamma-subunit complex binding | 2 | GNA12, GNAS |
|  cell shape | 2 | GNA12, DIAPH1 |
| cell differentiation | 2 | GNA12, UNC45B |
|  TOR signaling | 2 | GNA12, MIOS |
| lateral plasma membrane | 2 | GNA12, GPSM2 |
| DNA binding | 2 | MLLT10, PDCD5 |
|  transcription by RNA polymerase II | 2 | MLLT10, CDC73 |
| cell projection | 2 | FBXO45, CCT4 |
| adenylate cyclase-activating dopamine receptor signaling pathway | 2 | GNG2, GNAS |
| extracellular space | 2 | MFAP4, MOV10 |
| actin cytoskeleton organization | 2 | DIAPH1, PDCL3 |
| perinuclear region of cytoplasm | 2 | UNC45B, PDCL3 |
| transcription elongation by RNA polymerase II | 2 | CDC73, SKIC8 |
| negative regulation of cell population proliferation | 2 | CDC73, PDCD5 |
| negative regulation of myeloid cell differentiation | 2 | CDC73, SKIC8 |
| chromosome, telomeric region | 2 | CDC73, NLRP2 |
| Cdc73/Paf1 complex | 2 | CDC73, SKIC8 |
| nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay | 2 | SKIC3, SKIC8 |
| rescue of stalled ribosome | 2 | SKIC3, SKIC8 |
| euchromatin | 2 | SKIC3, SKIC8 |
| Ski complex | 2 | SKIC3, SKIC8 |
| intracellular membrane-bounded organelle | 2 | VBP1, NLRP2 |
|  telomerase activity | 2 | CCT2, CCT4 |
| scaRNA localization to Cajal body | 2 | CCT2, CCT4 |
| azurophil granule lumen | 2 | CCT2, CCT8 |
| intermediate filament cytoskeleton | 2 | PFDN5, CCT8 |
| cytoplasmic ribonucleoprotein granule | 2 | MOV10, SHB |
| angiogenesis | 2 | SHB, PDCL3 |
|  gene expression | 2 | PDCL3, PDCD5 |
| negative regulation of chaperone-mediated protein folding | 2 | PDCL3, PDCD5 |
|  cysteine-type endopeptidase activity involved in apoptotic process | 2 | PDCD5, NLRP2 |
| cilium | 2 | PDCL, CCT8 |
| cadherin binding | 2 | TXNDC9, CCT8 |

